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Abstract
In this study, we synthesized hybrid nanocubes composed of magnetite (Fe3O4) and manganese 
dioxide (MnO2), coated with U-251 MG cell-derived membranes (CM-NCubes). The CM-NCubes 
demonstrated a concentration-dependent oxygen generation (up to 15%), and, for the first time in 
literature, we showed an intracellular increase of temperature (6°C) due to the exothermic 
scavenging reaction of hydrogen peroxide (H2O2). Internalization studies demonstrated that the 
CM-NCubes were internalized much faster and at a higher extent by the homotypic U-251 MG 
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cell line compared to other cerebral cell lines. The ability of the CM-NCubes to cross an in vitro 
model of the blood-brain barrier (BBB) was also assessed. The CM-NCubes showed the ability to 
respond to a static magnet and to accumulate in cells even under flowing conditions. Moreover, we 
demonstrated that 500 μg ml-1 of sorafenib-loaded and unloaded CM-NCubes are able to induce 
cell death by apoptosis in U-251 MG spheroids that were used as a tumor model, after their 
exposure to an alternating magnetic field (AMF). Finally, it was shown that the combination of 
sorafenib and AMF induces a higher enzymatic activity of caspase 3 and caspase 9, probably due 
to an increment in reactive oxygen species (ROS) by means of hyperthermia.
Keywords
cell membrane-coated nanocubes; glioblastoma; homotypic targeting; magnetic hyperthermia; 
theranostics
1 Introduction
According to the 2016 World Health Organization (WHO) classification of tumors, 
glioblastoma multiforme (GBM) is one of the most commonly diagnosed brain cancers. This 
neoplasia, characterized by astrocytic differentiation, is one of the most aggressive central 
nervous system malignancies, resulting in poor prognosis and low survival rates mostly due 
to its late diagnosis.[1] Current treatment strategies include tumor resection using 
combinatory adjuvant or neoadjuvant radiotherapy and chemotherapy, but they fail to 
successfully treat GBM due to various reasons, including the location and the 
pathophysiology of the tumor, the hypoxic microenvironment that has been proven to be 
related to the multidrug resistance (MDR) phenomenon,[2] and the blood-brain barrier 
(BBB), that hinders the efficient delivery of various anticancer drugs.[1b, 3]
Since surgical resection is not always feasible, and since chemotherapy and radiotherapy are 
at a greater extent palliative than curative exhibiting reduced effectiveness together with 
pronounced side-effects, novel methodological approaches are to be developed for the 
treatment of various brain cancers including glioblastoma. These methods make use of smart 
drug delivery systems (DDS) able to cross the BBB and to specifically target the diseased 
tissue. These nanovectors may be stimuli-responsive, and take advantage of the tumor 
microenvironment resulting in alterations of their morphological and/or physicochemical 
properties, depending on the biological, physical and/or chemical cues.[4]
One of the best-studied systems that make use of an external stimulus in order to kill cancer 
cells is represented by superparamagnetic iron oxide nanoparticles (SPIONs). SPIONs 
constitute an attractive therapeutic system for solid tumors, due to the fact that they i) 
present negligible cytotoxicity, ii) can be easily modified to target specific types of cancer, 
iii) have the ability to encapsulate a variety of drugs, iv) in principle can be magnetically 
guided to the site of interest, v) can be used as diagnostics agent due to their ability to act as 
contrast agents in MRI, and vi) eventually they can kill cancer cells through magnetic fluid 
hyperthermia under the influence of an alternating magnetic field. All of these 
characteristics render SPIONs promising candidates for non-invasive cancer treatment.[4c, 5]
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Another type of inorganic nanoparticles that started to be used in the latest 5 years for the 
treatment of cancer and other inflammatory diseases is represented by manganese dioxide 
(MnO2) nanoparticles. MnO2 nanoparticles have the ability to scavenge hydrogen peroxide 
(H2O2) by producing oxygen.[2, 6] This combination leads to a reduction of oxidative stress 
that has been related to tumor cell survival, proliferation, and angiogenesis,[7] as well as with 
the regulation of the hypoxia-inducible factor-1α (HIF-1α) due to oxygen generation, that 
has also been associated to neovascularization, metastasis, and other phenomena. [8]
Despite both SPIONs and MnO2 nanoparticles can act as therapeutic enhancers, they are still 
not so effective to completely eliminate a tumor. Aiming at further enhancing their 
therapeutic activity, these nanoparticles can be loaded with chemotherapeutic agents like 
temozolomide (TMZ), and through a combinatory effect to increase their efficacy. Despite 
the fact that the TMZ is the most used FDA-approved chemotherapeutic agent in 
glioblastoma, sorafenib (SOR), a tyrosine protein kinase inhibitor (TPKI), has been also 
used in phase I and II clinical trials with and without TMZ aiming at treating glioblastoma, 
among other types of cancer[9].
A successful delivery system is also characterized by its ability to safely deliver its 
encapsulated therapeutic compound to a specific tissue. In order to achieve this aim, the 
surface of the DDS can be functionalized with targeting moieties able to bind specific 
receptors that are over-expressed in cancer cells. In spite of the fact that several 
functionalization techniques have been used over the years, the amount of therapeutics that 
can cross the BBB is still very low.[10] This phenomenon can be attributed to the strong 
endothelial cell tight junctions of the BBB that make central nervous system inaccessible,[3] 
as well as to the excretion of the DDS from the circulatory system through opsonization.[11] 
Aiming at overcoming these limitations, cell membrane coatings are starting to be used as a 
more biomimetic approach for the fabrication of smart DDS. The cell membrane provides 
stealth abilities to the coated DDS inhibiting its uptake by macrophages, and in many cases 
can lead to a homotypic cell targeting, demonstrating specific targeting ability.[12]
Herein, taking into consideration the limitations that the current treatment and delivery 
strategies present, and acknowledging the complex milieu of cancer microenvironment, we 
hypothesized that a multi-functional approach will lead to a bemeficiary therapeutic 
outcome. In view of this, we fabricated nanoparticles based on an inorganic core composed 
of magnetite (Fe3O4) and MnO2 in the form of nanocubes (NCubes), which were then 
coated with U-251 MG cell-derived membranes. These NCubes were able to scavenge an 
excess of hydrogen peroxide (H2O2), and at the same time to increase O2 levels in a 
concentration-dependent manner, due to the MnO2 component, while the Fe3O4 presence 
guaranteed the ferromagnetic character, thus, the guidance by external static magnetic field 
together with magnetic particle hyperthermia efficiency. Furthermore, the synthesized 
inorganic NCubes were able to induce apoptosis and necrosis in U-251 MG spheroids 
through hyperthermia and demonstrated an enhanced apoptotic effect when loaded with the 
chemotherapy drug sorafenib. The CM-NCubes were also tested for their ability to act as 
Magnetic Resonance Imaging (MRI) contrast agents, and it was found that their relaxivity r2 
was higher than that one of commercial contrast agent Endorem® withdrawn from the 
market in the last years.[13] Furthermore, we demonstrated that the CM-NCubes were able to 
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cross an in vitro model of the BBB and that the cell membrane coating resulted into a higher 
internalization owing to a homotypic binding to U-251 MG cells. Aiming at fully exploiting 
the magnetic component of the CM-NCubes, we assessed the combinational effect of a static 
magnetic field in close proximity to a dynamic microfluidic BBB in vitro model that 
consisted of an upper chamber seeded with bEnd.3 cells and a lower static compartment 
seeded with U-251 MG cells. [14] The results of this experiment demonstrated that under the 
effect of the static magnetic field the internalization and the subsequent crossing of the CM-
NCubes through the bEnd.3 cell layer is significantly faster.
2 Results and discussion
2.1 Morphological and physicochemical characterization
NCubes were synthesized using a simple one-pot procedure as described below, and a 
thorough physicochemical analysis was performed. The coating of the plain NCubes with 
cell membrane-derived lipids was performed aiming at the fabrication a multifunctional 
system, as presented in Fig. 1A. The first investigation that has been carried out was 
transmission electron microscopy (TEM) (Fig. 1B), that allowed the observation of the 
formation of cell membrane coated nanocubes with an average diameter of 20 ± 3 nm.
Infrared spectroscopy (Fig. 1C) of both uncoated (NCubes) and coated nanocubes (CM-
NCubes) demonstrated the successful presence of Fe-O and Mn-O bonds in the range 500 – 
700 cm-1 and 650 – 860 cm-1, respectively. It has to be noted that the vibrations of the peaks 
ascribed to the bonds of ‘metal-oxygen’ are interfering each other, resulting into a small 
shift in comparison to other reported values in the literature. [15] The broad peak at 
approximately 1750 cm-1 that can be seen only in the CM-NCubes spectrum can be 
attributed to the C-N and C=O vibrations of the cell membranes; the same applies for the 
peaks around 2800 cm-1, which are attributed to the C-H vibration. The small peak that is 
observed also around at 2800 cm-1 in NCubes can be probably attributed to an impurity 
since during the synthetic procedure, no organic compounds are used.
In order to assess the crystalline structure of the synthesized NCubes and CM-NCubes, we 
performed X-ray diffraction analysis (XRD) and the results that are presented in Fig. 1D 
demonstrate that both NCubes and CM-NCubes present the spinel structure of magnetite. In 
addition to this, the peak at 2θ = 38.6° is attributed to the MnO2, as it can also be seen from 
the XRD graph and the detailed XRD analysis presented in the supporting information (Fig. 
S2, Fig. S3, Table S1, and S2, ESI†), suggesting that we have both the crystalline structures 
in the synthesized NCubes and in the CM-NCubes. Using the Scherrer’s equation B = K · 
λ/L · cos θ’ (where K is a dimensionless shape factor and is equal to 0.94, λ is the 
wavelength of the electron source and is equal to 0.154 nm, and L is the full width at the half 
maximum of a chosen peak), we were also able to calculate the crystallite size of the CM-
NCubes, which was found to be 18.3 ± 2.9 nm, which is in very close agreement with the 
TEM results.
When thermogravimetric analysis (TGA) (Fig. 1E) was performed on the plain NCubes no 
weight reduction was observed, whilst a reduction that started above 100°C, and that can be 
attributed to the degradation of the cell membranes, could be observed for the CM-NCubes. 
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The remaining percentage of the CM-NCubes at 600°C was approximately 88%, indirectly 
demonstrating that the cell membrane surrounding the CM-NCubes comprises 12% of the 
total weight.
X-ray photoelectron spectroscopy (XPS) was also used as a complementary technique to 
prove the coating of the NCubes with cell membranes, and the results are presented in Fig. 
1F. Although both the spectra (NCubes and CM-NCubes) present C and N, it can be 
observed (see also Table S3 and Table S4, ESI†) that the percentages of these elements for 
the CM-NCubes are higher with respect to the control, suggesting the presence of a cell 
membrane layer. Moreover, according to the data derived from the deconvolution of the XPS 
peak of iron, it was calculated that the ratio of Fe(3+) / Fe(2+) is equal to 2, a value that is in 
agreement with other studies[16].
Inductively coupled plasma - optical emission spectrometry was also performed aiming to 
exactly calculate the percentages of Fe and Mn, as well as to further verify the presence of a 
cell membrane. The results for the uncoated NCubes showed a concentration of 67.2% Fe 
and 6.1% Mn, while for the CM-NCubes showed 62.5% Fe, 5.86% Mn and 0.22% P, 
suggesting the presence of a phospholipidic layer. Furthermore, the reduced value of Fe/Mn 
ratio on the surface of NCubes, which is 5.5/1 calculated by XPS, with respect to the ratio of 
the whole structure (11/1) as it can be calculated from the inductively coupled plasma 
optical emission spectroscopy (ICP-OES), shows that the percentage of Mn is higher on the 
surface of the CM-NCubes.
In order to visualize the location of the elements on the CM-NCubes, as well as to quantify 
these elements, we performed electron dispersive X-ray analysis. The results presented in 
Fig. 1G-1 – Fig. 1G-6 are related to the CM-NCubes, and demonstrate the homogeneous 
distribution of the elements on a single nanocube, further supporting XPS and ICP results 
outlining the presence of a cell membrane layer on the CM-NCubes. We would like to 
highlight that we tried to visualize the cell membrane coating using transmission electron 
microscopy, but this method was proved to be unsuccessful, probably due to the low 
thickness of the coating. Nevertheless, the electron dispersive X-ray analysis performed on a 
sample of plain NCubes (Fig. S1, ESI†) did not show any carbon or phosphorus content, 
contrarily to analysis performed on CM-NCubes (Fig. 1 G1-G6): an evidence that further 
supports the presence of an organic coating on the CM-NCubes. A complementary method 
that we used to verify the presence of a cell membrane component around the particles was 
the sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). As it can be 
observed in Fig.S3-A, the CM-NCubes samples (at different concentrations: 125, 250 and 
500 μg ml-1; Fig. S4 - Lanes 1, 2 & 3, ESI†) present molecular weight bands in the range of 
15 – 25 kDa. As the concentration of the CM-NCubes increases, darker bands that 
correspond to higher amounts of cell membrane proteins are observed. On the other hand, no 
band can be observed for the uncoated NCubes sample (Fig. S4 - Lanes 4 & 5, ESI†), thus 
proving the presence of cell membrane material on the CM-NCubes.
Lanes 6 and 7 and the ESI† correspond to a standard molecular weight marker (Sigma 
Aldrich) and the corresponding ladder. Finally, mass spectroscopy was performed in order to 
verify the protein content on the surface of the CM-NCubes. Mass spectroscopy was used to 
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characterize the protein content of both the raw product (extracted cell membrane) and the 
product adhering on the surface of the CM-NCubes. The results that are presented in Fig. 
S4-B, Fig. S4-C and Fig S4-D, ESI†, demonstrate that same proteins are present in the two 
samples, suggesting that the coating procedure of the CM-NCubes does not alter the 
qualitative content of the cell proteins. Furthermore, some of the identified proteins, 
including basigin (BSG), cluster differentiation-44 (CD44), catenin beta 1 (CTNNB1), 
myosin light-chain kinase (MYLK), tight junction protein 1 (TJP1), endothelial growth 
factor (EGFR) and cluster differentiation-59 (CD59), that were found after the analysis of 
the MS data, have been shown to be present and overexpressed on the surface of 
glioblastoma cells, [17] and this may be one of the reasons for the enhanced internalization of 
the CM-NCubes that is described later.
2.2 Stability studies and protein corona formation
It is well-known that the behavior of nanostructure-based drug delivery systems dramatically 
changes after their administration in vivo due to several reasons, which include their 
interaction with the proteins present in various body fluids, such as the blood and/or the 
cerebrospinal fluid. These interactions may affect the colloidal stability of the 
nanostructures, subsequently affecting their targeting and release abilities. In order to 
evaluate how well-known proteins in the blood and in the cerebrospinal fluid can affect the 
stability of the fabricated NCubes and CM-NCubes, we performed dynamic light scattering 
studies choosing as dispersants distilled water, Dulbecco’s Modified Eagle Medium 
(DMEM), and artificial cerebrospinal fluid (aCSF). Distilled water was used as a reference 
for the evaluation of the colloidal stability since it does not contain any salts and/or 
supplements that may affect the hydrodynamic size and/or the polydispersity of both 
NCubes and CM-NCubes. DMEM with supplements was used in order to assess the 
behavior of the NCubes and CM-NCubes concerning in vitro studies, while aCSF was used 
in order to assess the behavior of the CM-NCubes in a fluid simulating the mixed cerebral-
interstitial fluid of the neurovascular unit. [18] For these studies, we have also chosen to use 
as a supplement Fetal Bovine Serum (FBS) which is routinely used in cell cultures, and as 
model proteins transferrin (TrF), albumin (Alb) and ferritin (FrT). It has to be noted that the 
concentrations that were chosen for each protein were modified based on the literature, and 
correspond to the amounts that can be found both in the cell culture media and in the 
cerebrospinal fluid.[19]
The results that are presented in Fig. 2 demonstrate different behaviors depending on the 
combination of NCubes/CM-NCubes and proteins that are tested. When FBS or Alb are 
used, NCubes and CM-NCubes demonstrate excellent colloidal stability as it can be seen in 
Fig. 2A-1 and 2A-3 and in Fig. 2B-1 and 2B-3 for NCubes and CM-NCubes, respectively. 
When other proteins like transferrin and ferritin are used, we see that the nanoparticles start 
to aggregate resulting in multimodal populations (Fig. 2A-2 and 2A-4 for NCubes using TrF 
and FrT, respectively, and Fig. 2B-2 and 2B-4 for CM-NCubes using TrF and FrT, 
respectively), with increased hydrodynamic diameters and high polydispersity. Since 
albumin is the main component of FBS and since both albumin and FBS data show similar 
behavior, we assumed that albumin is the protein that interacts with the fabricated NCubes 
and CM-NCubes and increases their stability inside the aCSF. In order to further strengthen 
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our assumption, we assessed the behavior of NCubes and CM-NCubes in aCSF containing 
albumin, transferrin, and ferritin, and we have seen that the polydispersity and the 
hydrodynamic diameter is decreased for both NCubes and CM-NCubes, having the best 
results in terms of stability for the cell membrane-coated particles. These results not only 
suggest that the colloidal stability of the nanoparticles is affected mostly from albumin, but 
also that the cell membrane-coated particles differently interact compared to the uncoated 
ones. This behavior can be attributed to the fact that the NCubes have a high surface area (34 
m2 g-1) and nanopores in the range of 2 nm (Fig. S5-A and Fig. S5-B ESI†), that allows 
more proteins to be physically adsorbed on their surface resulting into the creation of a thick 
protein corona layer composed by all the supplemented proteins, and that leads to the 
distributions observed in Fig. 2A-5.
In order to further evaluate the colloidal stability of the particles, we performed dynamic 
light scattering studies at different time points (0, 1, 6 and 24 h) in distilled water, DMEM 
and DMEM + 10% FBS (Fig. S6, ESI†). The results demonstrated that both coated and 
uncoated samples are stable up to 6 h when they are dispersed in distilled H2O or DMEM 
+ 10% FBS. At all the time points up to 6 h, CM-NCubes present a lower average 
hydrodynamic diameter (120.0 ± 2.8 nm in H2O and 165.0 ± 6.1 nm in DMEM + 10 % 
FBS) compared to the uncoated NCubes (198.0 ± 23.3 nm in H2O and 264.0 ± 4.5 nm in 
DMEM + 10 % FBS) and this may be attributed to an increased stability because of the 
coating. The higher colloidal stability that is presented in distilled water compared to the 
other two used media may also be attributed to the negative surface charge of -17.2 ± 0.2 
mV for the NCubes and of -20.9 ± 0.4 mV for the CM-NCubes. Due to the high ionic 
strength of DMEM, the results for the NCubes and CM-NCubes are similar, suggesting the 
creation of aggregates. The results are more evident after 24 h, when the NCubes present a 
value of 1.2 ± 0.1 μm and 250.0 ± 6.2 nm for H2O and DMEM + 10% FBS respectively 
(Fig. S6A-4, ESI†), in contrast to the coated ones (Fig. S6B-4, ESI†), where the average 
hydrodynamic diameter is 272.0 ± 5.1 and 160.0 ± 3.0 nm for H2O and DMEM + 10% FBS, 
respectively.
In order to assess how the oxidative microenvironment of the tumor may affect the stability 
of the CM-NCubes, we performed again dynamic light scattering studies incubating the 
particles with increasing concentrations of H2O2 (0.05, 0.25 and 1 mM) diluted in aCSF, 
which is a biologically relevant medium, containing albumin as a protein stabilizer, in order 
to simulate the various conditions of oxidative stress in glioblastoma. Although the 
concentration of H2O2 1 mM is quite high, we used it as a positive control in order to be sure 
that the cell membrane will be affected. These preliminary results (Fig. S7, ESI†) 
demonstrated that even at a concentration of H2O2 0.05 mM, after 72 h, the stability of the 
CM-NCubes can be affected, probably due to the lipid peroxidation of the cell membrane 
that can subsequently lead to partial membrane degradation. Similar behavior could also be 
observed as well at higher H2O2 concentrations.
2.3 Magnetic characterization and magnetic hyperthermia studies
In order for a hyperthermia-inducing agent to be successful, properties like high saturation 
magnetization, high specific absorption rate (SAR) and high intrinsic loss power (ILP) are 
Tapeinos et al. Page 7
Adv Healthc Mater. Author manuscript; available in PMC 2019 September 20.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
needed. Aiming at assessing these properties, a series of magnetic characterization and 
response to external alternating magnetic fields have been carried out.
The magnetic properties of NCubes and CM-NCubes are presented in Fig. 3A, and show 
that the saturation magnetization is approximately 57 emu g-1 for the uncoated NCubes and 
40 emu g-1 for the CM-NCubes, while the coercivity is approximately 12 mT for both 
NCubes and CM-NCubes. These values are close to those of nanoparticles reported in other 
studies,[20] and they show the potential ability of the CM-NCubes to be used as therapeutics 
for cancer.
After assessing the magnetic properties, we evaluated the ability of NCubes and CM-
NCubes to increase the temperature of the surrounding medium under the influence of an 
alternating magnetic field, in three different media. From the graph presented in Fig. 3B, 
where 5 mg ml-1 of NCubes or CM-NCubes are exposed to a magnetic field of 20 mT with a 
frequency of 750 KHz, it can be observed that CM-NCubes behave better in terms of heating 
rate with respect to the uncoated ones. More specifically, CM-NCubes in water have the 
ability to increase the temperature from 32.5°C to 60.0°C in 60 min, while the 
corresponding uncoated ones reach 40°C in the same timeframe. Similar behavior can be 
observed when other media (DMEM and DMEM + 10% FBS) are used. This behavior can 
be probably attributed to the faster precipitation of the uncoated NCubes in media with high 
ionic strength (DMEM and DMEM + 10% FBS), leading to their accumulation at the 
bottom of the vial and outside the area where the magnetic field presents its maximum 
intensity. On the other hand, although the ability of the CM-NCubes to increase temperature 
is also affected by the used medium, still a higher temperature can be achieved after 60 min 
with respect to the NCubes, and this can be attributed to the increased colloidal stability that 
they present, probably due to the phospholipid cell membrane coating. This stability allows 
the CM-NCubes to be homogeneously dispersed for longer periods, thus taking advantage of 
the maximum intensity of the magnetic field. Plain media (H2O, DMEM and DMEM + 10% 
FBS) without coated or uncoated nanocubes were used as controls and the results are also 
presented in Fig. 3B. In order to assess the ability of the CM-NCubes to be used as a 
hyperthermia-inducing agent, we have calculated the SAR and the ILP values under various 
magnetic field intensities, various frequencies, and in various media. The results presented in 
Fig. 3C and Fig. 3E demonstrate that we can precisely control properties like SAR and ILP 
by controlling the magnetic field and the frequency, suggesting the precise control of the 
heating rate and the maximum temperature that can be achieved using a desired CM-NCubes 
concentration. It has to be noted that the best results were acquired when an AMF of 20 mT 
at 750 KHz and a 9 turn-44 mm coil were used, and for these parameters the highest 
obtained SAR and ILP values were 78.6 ± 3.9 W g-1 and 0.40 ± 0.02 nHm2 kg-1, 
respectively, values that are higher with respect to commercial Fe3O4 nanoparticles reported 
in the literature. [21] It has to be mentioned that high values of SAR (49.6 ± 2.4 W g-1) and 
ILP (0.80 ± 0.04 nHm2 kg-1) were also obtained using a 56 mm coil and 12 mT at 657 KHz 
of AMF, values close to the Brezovich limit (4.85 × 108 A m-1 s-1). [22] Nevertheless, for the 
in vitro evaluation of the CM-NCubes we have decided to use the maximum possible 
magnetic field and frequency, in order to overcome the limited heating efficiency. [20, 23] 
After assessing the effect of various magnetic field intensities and different coils, we 
evaluated the effect of the solvent on SAR and ILP values of NCubes and CM-NCubes (Fig. 
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3D and Fig. 3F). As expected from the results in Fig. 2B, the highest SAR and ILP values 
were obtained for CM-NCubes in water (78.6 ± 3.9 W g-1 and 0.40 ± 0.02 nHm2 kg-1), 
followed by the same particles in DMEM + 10% FBS (63.0 ± 3.2 W kg-1 and 0.33 ± 0.02 
nHm2 kg-1), and then in plain DMEM (53.8 ± 2.7 W g-1 and 0.28 ± 0.01 nHm2 kg-1). These 
results along with the temperature increment that is presented in Fig. 2B suggest that the 
ionic strength of the solvent and/or the supplements (e.g., fetal bovine serum) in the medium 
have an effect on the SAR and ILP values, since they directly affect the colloidal stability of 
both NCubes and CM-NCubes (Fig. S6).
Overall, the results demonstrated that the CM-NCubes can act as hyperthermia-inducing 
agents not only in water but also in simulated body fluid media. Since magnetite 
nanoparticles have been robustly reported as good magnetic resonance imaging (MRI) 
contrast agents, [5, 24] we performed NMR relaxometry studies in order to evaluate the 
ability of the CM-NCubes to act as well as diagnostic tools. The results presented in the 
supporting information (Table S5 and Fig. S8, ESI†) demonstrated that the CM-NCubes can 
be potentially used as T2 MRI contrast agents, since they present relaxivity values r2 = 
174.60, 184.80, and 182.13 s-1mm-1 at frequencies of 56.7, 21.3 and 8.5 MHz respectively, 
that cover most of the typical fields, H = 1.33 T (near H=1.5 T), 0.5 T and 0.2 T respectively, 
of MRI tomographs used both in clinics and in research laboratories. It has to be noted that 
the commercial T2 MRI contrast agent Endorem® shows r2 ≅ 100 s-1mm-1 (in the range 8.5 
MHz < ν < 60 MHz).[13] In addition to NMR relaxometry studies, phantom images of CM-
NCubes dispersions, water, and of the commercial contrast agent Endorem®, for a high 
resolution Spin Echo sequence, are presented in Fig. S8-B. It is clear that the CM-NCubes 
signal is darker (41.6% ± 1.4% signal intensity compared to the water signal which was 
considered as 100%) than Endorem® (45.7% ± 2.5% signal intensity compared to the water 
signal) at a similar concentration (0.08 mM for CM-NCubes and 0.1 mM for Endorem®) of 
the magnetic component, and therefore shows a better performance as a negative contrast 
agent at the imager operating frequency (8.5 MHz).
2.4 Oxygen generation and temperature increase due to ROS scavenging
It is well-known that solid tumors share some common characteristics, like the 
overproduction of ROS and the hypoxic microenvironment.[8a, 8b]Moreover, hypoxia has 
been related to increased angiogenesis and metastatic spreading of cancer cells, as well with 
the multidrug resistance phenomenon.[8b–d] Taking this into consideration, we hypothesized 
that the MnO2 component of the CM-NCubes could scavenge the overproduced ROS, while 
at the same time will increase the oxygen levels due to the reaction of MnO2 with hydrogen 
peroxide.[6a, 6b, 6e] In addition, we hypothesized that since the scavenging reaction is an 
exothermic reaction, it will locally increase the temperature inside cells. In order to evaluate 
the increment of oxygen levels, we have tested five different concentrations of H2O2 (0, 
0.05, 0.25, 0.5 and 1 mM), interacting with three different concentrations of CM-NCubes. 
The results presented in Fig. 4A demonstrate that the amount of the oxygen produced is 
related both to the concentration of the CM-NCubes as well as to the concentration of the 
H2O2, as already shown in our previous study.[6b] Furthermore, it is noteworthy the fact that 
even at the lowest concentration of CM-NCubes (100 μg ml-1, Fig. 4A-1), where according 
to the ICP results the Fe/Mn ratio is 10.5 (meaning that the percentage of manganese is 10.5 
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times lower than iron, e.g., MnO2 ≈ 8.4 μg ml-1), an increment of oxygen concentration in 
the range 1-10% could be observed depending on the H2O2concentration used, suggesting a 
controlled generation of oxygen even at low concentrations of CM-NCubes. Similar results 
were also obtained when higher concentrations of CM-NCubes were used (Fig. 4A-2 and 
Fig. 4A-3), suggesting that the highest used concentration of H2O2 (1 mM) can be 
completely scavenged by using 100 μg ml-1 of CM-NCubes. In order to verify the 
scavenging ability of the fabricated CM-NCubes, we used a total antioxidant capacity assay 
kit, and we compared the antioxidant ability of the CM-NCubes with the antioxidant ability 
of Trolox, which is a standard analog of vitamin E. The results presented in Fig. S9 (ESI†) 
show, similarly to the oxygen generation results, that the antioxidant ability is dose-
dependent, with 100, 250 and 500 μg ml-1 of CM-NCubes to be analogue, in terms of 
antioxidant activity, to 17.5 ± 1.13 μM, 50.3 ± 3.2 μM and 103.3 ± 6.7 μM of Trolox, 
respectively.
As previously mentioned, the reaction between H2O2 and MnO2 is exothermic, and can 
possibly locally increase the temperature. In order to assess this ability, we measured the 
increment of temperature after the reaction between CM-NCubes and H2O2 at the same 
concentrations used for the oxygen generation measurements. The results presented in Fig. 
4B show an increment of temperature up to 0.75°C (Fig. 4B-1 and Fig. 4B-2) when the 
highest concentration of H2O2 (1 mM) is used, while a temperature increase around 0.25°C 
can be observed for lower concentrations of H2O2. Since the ability of CM-NCubes to 
increase temperature was proved by simply allowing the reaction between MnO2 and H2O2, 
we evaluated the ability of the system to increase the intracellular temperature. In order to 
achieve this, we treated U-251 MG cells with CM-NCubes (250 μg ml-1) overnight, and 
subsequently, we stained the cells with a temperature sensitive dye as previously described.
[25]
 Then, by using confocal microscopy, we recorded the difference in terms of fluorescence 
intensity in cells incubated with CM-NCubes, after the addition of DMEM supplemented 
with 25 mM of (4-(2-hydroxyethyl)-1-piperazine ethane sulfonic acid) (HEPES) (Fig. 4C, 
Control, and Video S1, ESI†) and after the addition of 100 μM of H2O2 in DMEM 
supplemented with HEPES (Fig. 4C, Treated, and Video S2, ESI†). In addition, in order to 
check the effect of the plain H2O2, we also performed studies using a second control, which 
we considered as a negative control (N. Control), where 100 μM of H2O2 in DMEM 
supplemented with HEPES was added to non-treated U-251 MG cells (Fig. 4C, N. Control, 
and Video S3, ESI†). It is evident from the reported representative images that until 80 s all 
the samples demonstrate a stable fluorescence intensity, which remains stable when DMEM 
supplemented with HEPES is added in the CM-NCubes treated cells or when H2O2 is added 
in the plain U-251 MG cells, while after the addition of H2O2 in the CM-NCubes treated 
cells, the fluorescence intensity is significantly reduced. The reduction in the fluorescence 
intensity was translated in terms of temperature increment (Fig. 4D), and it was found that 
the intracellular temperature increased by 6°C in the samples treated with 100 μM H2O2, in 
contrast to the control cultures that were treated just with DMEM supplemented with 
HEPES or the negative control samples where U-251 MG cells without particles were 
treated with 100 μM of H2O2. It must be stressed that the intracellular temperature increase 
that it is here presented should not be confused with the temperature measurement of the 
medium. In the first case, we measure a local rise in temperature, while in the second case, 
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we measure the temperature of the whole medium. In this regard, our work is in agreement 
with studies where temperature-sensitive probes are used, and where a local temperature 
increment, using similar systems, is observed. [26] Another reason for the observed 
difference in temperature increment may lay in the fact that there is a localized accumulation 
of the CM-NCubes inside the cells, and this accumulation potentially enhances the 
temperature increment.
We would like to stress out the fact that this is the first time that a drug delivery system like 
the presented one is shown to increase the intracellular temperature due to a simple ROS 
scavenging effect. These data suggest that it is possible to develop ROS-responsive systems 
presenting the ability to induce hyperthermia by simply scavenging the overproduced ROS 
in the cancerous microenvironment.
2.5 Loading and release studies
The ability of the CM-NCubes to be loaded with a chemotherapeutic drug and their ability to 
release this drug in a controlled manner was assessed through loading and release studies. 
Loading assessment showed that CM-NCubes can have an encapsulation efficiency (%EE) 
of 94.6± 4.6%, and dynamic loading (%DL) of 8.6 ± 1.2%.
The release studies (Fig. S10, ESI†), were performed at two different pH values (7.4 and 
4.5), that respectively correspond to physiological pH and pH that can be found in the 
intracellular acidic organelles like lysosomes, as well as under the influence or not of an 
alternating magnetic field. The results demonstrate a slow and sustained release of SOR for a 
period of 192 h, even when two different stimuli like AMF and pH are applied.
After 6h, the release at pH 7.4 without and with AMF is respectively 5.5 ± 0.6% and 10.4 
± 2.6%, while at pH 4.5 without AMF and with AMF it is respectively 10.6% ± 2.1% and 
11.3 ± 5.0%. Although there is a difference between pH 7.4 and pH 4.5 with and without the 
presence of the AMF, this difference is not significant and may be attributed to a burst 
release occurring during the first hours. Nevertheless, the released amount of sorafenib at 
this time point is very low, and cannot be considered significant. After 192 h the cumulative 
release at pH 7.4 reaches 23.0% ± 0.9%, at pH 7.4 + AMF reaches 28.3% ± 2.4%, at pH 4.5 
reaches 45.0% ± 1.9% and finally at pH 4.5 + AMF reaches 51.9% ± 1.9%. These results 
demonstrate that there is a controlled and sustained release over a period of 192 h which can 
be modulated by combining different temperatures and pH values.
2.6 Targeting ability – Internalization studies
In order to assess the ability of CM-NCubes to be specifically internalized by the homotypic 
U-251 MG cell line, we carried out experiments using four different cell lines, as well as 
NCubes covered by a biocompatible lipid-based coating as a control. The chosen cell lines 
were, besides U-251 MG, C8-D1A (astrocytes) and bEnd.3 (endothelial cells) as the main 
cell lines that constitute the BBB model, and SH-SY5Y as a different type of brain cancer 
cells. Furthermore, we also assessed the internalization of NCubes functionalized with a 
lipid-based coating (LP-NCubes) made of biocompatible lipids (e.g., cetyl palmitate, 
glycerol monooleate, and 1,2–distearoyl–sn–glycerol–3–phosphoethanolamine–N–
[methoxy(polyethylene glycol)]), already reported in the literature also by our group.[20, 27] 
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The internalization was assessed by using both flow cytometry and confocal microscopy. 
The results presented in Fig. 5A and 5B make evident that there is preferential uptake of 
CM-NCubes with respect to LP-NCubes for all the cell lines, with the exception of the 
bEnd.3, that apparently after 4 h shows a higher internalization of LP-NCubes compared to 
the CM-NCubes. Despite this qualitative evidence, the statistical analysis (one-way 
ANOVA, Table S6, ESI†) show that this difference is not significant. Furthermore, a non-
significant difference was also observed between LP- and CM-NCubes tested on C8-D1A 
and SH-SY5Y cells, while the difference was significant between LP- and CM-NCubes, in 
favor of CM-NCubes, in U-251 MG cells (p < 0.01). These results suggest that CM-NCubes 
show a preferential uptake by the homologous cancerous cell line with respect to the SH-
SY5Y, C8-D1A and bEnd.3 cells. Furthermore, there is a significant difference, with a 
preferential uptake, in the CM-NCubes internalization by the homotypic U-251 MG cell line 
(p <0.0001) with respect to the SH-SY5Y and C8-D1A, respectively.
2.7 Blood-brain barrier crossing
One of the biggest challenges for the treatment of glioblastoma, as well as of other central 
nervous system diseases, is the crossing of the BBB and the successful delivery of the 
pharmaceutical cargo in the pathological tissue. Aiming at assessing the ability of CM-
NCubes to cross the BBB, we used an in vitro cell culture model, previously described in 
another work of our group.[20] The results presented in Fig. 6A show a sustained passage of 
CM-NCubes that were incubated onto a monolayer of bEnd.3 cells, seeded on a 3 μm pore 
Transwell© insert, and that after 48 h, 75.0 ± 3.7% of the incubated CM-NCubes (calculated 
according to a standard curve of DiO-stained CM-NCubes previously performed), were able 
to pass the endothelial layer. These data show the potential of the fabricated system to be 
used as a biomimetic drug delivery system for the passage of the BBB. After BBB in vitro 
model crossing, CM-NCubes were efficiently internalized by U-251 MG cells, as 
demonstrated by confocal microscope observation (Fig. 6B, single acquisition, and Fig. 6C, 
Z-stack rendering).
2.8 Magnetic targeting using an in vitro dynamic model of the BBB
The ability of CM-NCubes to be attracted and accumulated into a specific area of interest in 
a microfluidic BBB in vitro model was assessed using a static magnetic field generated by a 
magnet. We further studied this accumulation by using a theoretical numerical model that 
was previously described by our group. [14]
The observed CM-NCubes distribution after exposure to a static magnetic field as shown in 
Fig. 7A (fluorescence intensity coded with pseudocolors) and Fig. 7B was successfully 
predicted by the numerical model that is presented in Fig. 7C. By accounting for viscous 
effects (fostering accumulation closer to the channel boundaries), the model predicted a 
higher density of captured CM-NCubes near the magnet top edge, as well as a lower density 
spread on the magnet top surface. After accumulation, CM-NCubes were able to be 
internalized by both the bEnd.3 cells seeded in the upper channel of the fluidic device as 
well as U-251 MG cells present in the lower compartment of the system. Without the use of 
a static magnet, the amount of CM-NCubes internalized by both cell lines was significantly 
reduced, as shown in Fig. 8.
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2.9 Magnetic hyperthermia-induced apoptosis, increased caspase activation and reactive 
oxygen (ROS) and nitrogen (RNS) species generation
The ability of CM-NCubes and SOR-CM-NCubes to induce apoptosis was studied with or 
without the exposure of U-251 GM spheroids to an external alternating magnetic field. The 
results presented in Fig.9A show that the alternating magnetic field does not have an effect 
to the plain U-251 MG spheroids (live cell: 91.3% ± 0.6%, early apoptotic cells 0.4% 
± 0.3%, late apoptotic cells 0.2% ± 0.1%,and dead cells 8.1% ± 0.2%). When the spheroids 
are treated with plain sorafenib (10 μg ml-1), early and late apoptotic cells as well as dead 
cells increase to 1.8% ± 0.5%,1.1% ± 0.2% and 10.9 % ± 0.4% without exposure to the 
AMF, and to 1.5% ± 0.2%, 2.8% ± 0.9% and 13.5% ± 3.7% % after their exposure to the 
AMF, respectively. These results, in combination to the performed statistical analysis, 
demonstrate that there is no significant difference in the viability of the U-251 MG 
spheroids, between the control and the group treated with SOR, with or without the exposure 
to the AMF.
On the other hand, when the U-251 MG spheroids are treated with CM-NCubes, there is an 
increase in late apoptotic (9.7% ± 4.6%) and dead (24.3% ± 0.1%) cells when an AMF is 
used. This increase in the dead cells is considered significant (p < 0.0001) compared to the 
control group. The spheroids incubated with CM-NCubes that have not been exposed to an 
AMF present 80.2% ± 0.3% of live cells, 2.1% ± 0.6% of early apoptotic cells, 1.7% ± 0.3% 
of late apoptotic cells and 15.9% ± 0.3% of dead cells versus 64.0% ± 4.3%, 1.9% ± 0.2%, 
9.7% ± 4.6%, and 24.3% ± 0.1%, respectively for the spheroids exposed to an AMF (Fig. 
S11, ESI†). These results demonstrate firstly that the CM-NCubes do not affect the viability 
of the spheroids since there is no significant difference between the control group and the 
group treated with CM-NCubes, unless if an AMF is applied. The group treated with CM-
NCubes and exposed to the AMF reduces the percentage of live cells to 64.0% ± 4.3% (p < 
0.0001 compared to the control). The effect of magnetic hyperthermia-induced apoptosis is 
more evident when sorafenib-loaded CM-NCubes are used. Without the use of an AMF, the 
percentage of live cells is 79.9% ± 4.9% and early apoptotic, late apoptotic and dead cells 
are 1.7% ± 0.1%, 1.4% ± 0.1%, and 17% ± 4.9%, respectively. The fact that SOR-CM-
NCubes do not significantly increase the percentage of apoptotic and dead cells suggests that 
the encapsulated sorafenib is slowly released from the CM-NCubes if the AMF is not 
applied. Conversely, the percentage of live cells when the AMF is used decreases to 55.3% 
± 4.5%, while the percentages of the early apoptotic, late apoptotic and dead cells changes to 
2.8% ± 1.0%, 14.4% ± 0.1%, and 27.6% ± 3.3%, respectively. It is obvious that increased 
apoptosis and cell death can be observed when a combination of sorafenib and AMF is used.
Aiming at further investigating the apoptotic pathway during hyperthermia, we assessed the 
enzymatic activity of caspase 3 and caspase 9. The results presented in Fig. 9B and Fig. 9C, 
respectively, and the statistical analysis (Table S7 and Table S8, ESI†) show that there is no 
significant difference in the activity of caspase 3 (cas-3) in the majority of the groups, with 
the exception of the SOR-CM-NCubes group after its exposure to the AMF where a 
significant difference (p < 0.5) is present (3.0 ± 0.2 fold increase), compared to the control 
group and to the group treated with the CM-NCubes but without AMF application (1.0 ± 0.5 
N-fold increase). In addition, a significant difference (p < 0.01) is also observed between the 
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group treated with sorafenib (0.6 ± 0.4 fold increase) and the SOR-CM-NCubes+AMF 
group (3.0 ± 0.2 fold increase). These results suggest that the cas-3 pathway is activated only 
when sorafenib and alternating magnetic field are combined, and this may be attributed to 
the small concentration of drug internalized by the cells when it is free, or because of its low 
release when the AMF is not applied (ca. 4.3 μM after 192h/pH 7.4 and 7.2 μM after 
192h/pH 4.5). These results are in agreement with the work of Rodríguez-Hernández et al. 
[28]
, where it was presented that small concentrations of sorafenib (10 nM) do not result in 
cas-3 activation, but they can induce activation of the caspase 9 (cas-9) pathway, whereas 
higher concentrations (10 μM) can result in the activation of the cas-3 pathway as well. The 
increased levels of cas-3 can also be attributed to the alternating magnetic field since it has 
been already reported[29] that magnetic hyperthermia induces cas-3 activation. Continuing in 
Fig. 9C, it is more evident that cas-9 activation levels are higher compared to the cas-3 
activation for the SOR-CM-NCubes groups, with and without an AMF, with the higher 
activity in the SOR-CM-NCubes+AMF group (7.5 ± 0.2 fold increase), which is 
significantly higher (p < 0.0001) with respect to the control group. Once more, a significant 
difference (p < 0.001) can be observed between the SOR group and the SOR-CM-NCubes
+AMF group. A more detailed statistical analysis is provided in Table S7 and Table S8, 
ESI†.
In order to assess whether the induced apoptosis is ROS/RNS-related, we also studied the 
increment of ROS and RNS level generation for each one of the tested conditions. The 
results presented in Fig.9D and Fig.9E respectively demonstrate that there is a significant 
increment in ROS generation in the CM-NCubes +AMF (5.5 ± 0.3 fold increase; p < 
0.0001), and SOR-CM-NCubes +AMF (5.0 ± 0.1 fold increase; p < 0.001) treatments, 
compared to the control groups, which may be related with the increased percentages of 
apoptotic and dead cells that were described above. An increment can also be observed in 
the groups treated with free CM-NCubes (2.3 ± 0.1 fold increase) and in the group treated 
with SOR-CM-NCubes (3.6 ± 2.2 fold increase), but this difference is not considered 
significant. Although a significant ROS generation was observed during the AMF treatment, 
no significant increase could be observed in the reactive nitrogen species in the tested 
conditions, suggesting that the induced apoptosis may be attributed to ROS generation. A 
more detailed statistical analysis is provided in Table S9 and Table S10, ESI†.
3 Conclusions
In this work, we synthesized a hybrid nanocube consisting of an inorganic core (Fe3O4/
MnO2) coated with a lipid layer extracted from cell membranes, derived from the U-251 MG 
cell line. These CM-NCubes presented good magnetic properties and NMR relaxation times, 
thus demonstrating their potential to be used as theranostic agents. Furthermore, the CM-
NCubes demonstrated good antioxidant capabilities due to H2O2 scavenging that led to a 
well-controlled and concentration-dependent oxygen generation. For the first time in the 
scientific literature, we were able to demonstrate an intracellular temperature increment 
caused by the exothermic reaction between CM-NCubes and H2O2, suggesting that it is 
possible to make use of the intracellular ROS to locally increase temperature and thus, 
contributing to hyperthermia. Moreover, it was demonstrated that CM-NCubes present a 
preferential uptake from the homotypic U-251 MG cell line compared to other brain cell 
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lines (C8-D1A, bEnd.3 and SH-SY5Y), as well as that the cell membrane coating 
significantly increases the internalization of the particles compared to other biocompatible 
lipid coatings. Using an in vitro BBB model it was shown that 75.0 ± 3.7% of the incubated 
CM-NCubes in the abluminal part of a Transwell© insert is able to pass through after 48 h, 
and to be subsequently internalized by U-251 MG cells. Using an in vitro dynamic model of 
the BBB, the possibility to magnetically accumulate CM-NCubes leading to a higher 
accumulation of the nanostructures from both bEnd.3 and U-251 MG cells was 
demonstrated. Finally, it was shown that the exposure of U-251 MG spheroids to an AMF 
for 3 days significantly increases apoptotic and necrotic cells as well as in caspase-9 levels, 
in the presence of CM-NCubes and SOR-CM-NCubes under the AMF. A higher increase in 
ROS levels was also observed for the samples treated with CM-NCubes and SOR-CM-
NCubes under the influence of the AMF, while no significant increase could be observed in 
the RNS levels. Although the acquired data are encouraging, we acknowledge the fact that 
the used models (BBB, 3D spheroids) have limitations, and much further investigation 
including in vivo studies (to elucidate pharmacokinetics, biodistribution, BBB crossing, in 
vivo hyperthermia, and MRI contrast features), are needed before considering the specific 
system suitable as a realistic theranostic platform for glioblastoma.
4 Experimental section
4.1 Preparation of CM-NCubes
Inorganic Fe3O4/MnO2 nanocubes (NCubes) were synthesized using a modified procedure 
previously reported in the literature. [30] Briefly, 695 mg (2.5 mmol) of iron sulfate 
heptahydrate (FeSO4·7H2O) were dissolved in 94 ml of distilled water, inside a 300 ml 
conical flask, and stirred for 1 h at 300 rpm, while in parallel 39.5 mg (0.25 mmol) of 
potassium permanganate (KMnO4) were dissolved in 5 ml of distilled water inside a 7 ml 
plastic vial, by shaking at 100 rpm for 1 h. Then, 1 ml of 5 M sodium hydroxide (NaOH) 
were added drop by drop using a syringe pump (1 ml min-1) in the iron solution and stirred 
for 10 min. Thereafter, the temperature was adjusted to 90°C, and while increasing, the 
potassium solution was added at the same speed as performed for the NaOH. The stirring 
speed increased to 500 rpm and the solution was left at this temperature for 12 h. Afterward, 
the solution was left to cool down at room temperature and cleaned three times using 
distilled water through centrifugation (10 min, 9000 rpm, 4°C). The precipitate was always 
kept in water and a small aliquot was freeze-dried in order to calculate the concentration of 
the final product.
In order to prepare cell membrane-coated CM-NCubes, we first extracted the cell membrane 
from the U-251 MG cell line using a modified procedure from a previously reported 
method[31]. Briefly, U-251 MG cells were cultured in DMEM with 10% of FBS (Gibco), 1% 
of penicillin/streptomycin (P/S, Thermo Fisher Scientific) and 1% of L-glutamine (L-glu, 
Thermo Fisher Scientific) in a humidified environment with 5% CO2 at 37°C. When cells 
reached confluence, they were detached from the 10 cm Petri dishes using 0.05% trypsin-
EDTA (Thermo Fisher Scientific). The cell dispersion was washed 3 times with Dulbecco’s 
phosphate buffer saline 1× (DPBS, Thermo Fisher Scientific) and re-dispersed in distilled 
water. The new cell dispersion was transferred to a high-pressure homogenizer (HPH, 
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Emulsiflex B15, Avestin) and the cell membrane was disrupted at a pressure of 6000 psi / 
412.5 bar with 10 passages. The disrupted cell-dispersion was centrifuged at 10000 rpm for 
10 min to remove debris and non-disrupted cell organelles, and the supernatant was 
centrifuged again at 60000 g for 90 min. The collected cell membranes were kept at 4°C 
until further use.
Concerning the coating, 2 mg of NCubes were dispersed in 1 ml of water and sonicated 
using a Fisherbrand™ Q125 Sonicator (50% amplitude) for 10 min at 4°C. Afterward, 1 ml 
of the extracted cell membranes (derived from 10·106 cells) was mixed with the NCubes 
dispersion and sonicated for a further 20 min at the same amplitude. Three cleanings with 
deionized water were carried out by spinning down the samples for 15 min at 16000 g at 
4°C.
As a control, the coating of the NCubes was moreover carried out with commercial lipids, 
by using a modified protocol previously reported by our group.[20] Briefly, 5 mg of dry 
NCubes were mixed with 6 mg of cetyl palmitate (Gattefosse), 2 mg glycerol monooleate 
(Sigma Aldrich), 2 mg of methoxy poly (ethylene glycol) (5000 g mol-1) -1,2-distearoyl-sn-
glycerol-3-phosphoethanolamine (mPEG-DSPE, DBA Italia), and 200 μl of chloroform 
(CHCl3, Sigma Aldrich) and sonicated for 20 min at 4°C using a Fisherbrand™ Q125 
Sonicator. After the complete dissolution of the lipids and the homogenization with the dry 
NCubes, 3 ml of pre-warmed (60°C) Tween® 80 solution (1% w/v, Sigma Aldrich) were 
added to the mixture and sonicated at 50% for 10 min using a Fisherbrand™ Q125 
Sonicator. The lipid-coated nanocubes (LP-NCubes) were cleaned 3 times with deionized 
water by spinning down the samples for 15 min at 16000 g at 4°C.
4.2 Morphological and physicochemical characterization
The morphological characterization of the CM-NCubes was performed using a transmission 
electron microscope FEI Tecnai G2 F20 TWIN TMP with a Schottky emitter operated at 200 
kV. The EDS analyses have been carried out by using a Bruker XFlash 6|T30 silicon-drift 
detector (SDD), with 30 mm2 effective area. Each sample has been sonicated for a few 
minutes to avoid the presence of aggregates. 5 µl of the solution have been dropped onto an 
ultrathin carbon-coated Cu grid. The samples were stained with 1% uranyl acetate before the 
TEM analysis. The analysis of the spheroids was carried out with a FEI 200 scanning 
electron microscope (SEM) operating at 5-20 keV, with beam currents varying from 43 pA 
to 0.17 nA. The elemental analysis was performed using a built-in Bruker Nano XFlash 
5010 detector. All of the samples were coated with gold at 25 mA for 70 s before analysis. 
The cross-sections of the samples were performed with the same microscope equipped with 
a focused ion beam delivering a 15keV beam of gallium (Ga+) ions, with beam currents 
varying between 43 pA to 0.17 nA.
XPS of the nanoparticles was performed with a SPECS instrument equipped with a Phoibos 
150 1D-DLD analyzer and with a monochromatized Al Kα (1486.6 eV) radiation source. 
Survey scans (1400 to 0 eV binding energy -BE-, step energy 1 eV, dwell time 0.1 s, pass 
energy 80 eV) were acquired with an electron take-off angle of 90°. High-resolution scans 
(step energy 0.1 eV, dwell time 0.1 s, pass energy 30 eV) were also acquired with an electron 
take-off angle of 90°. The hydrocarbon peak component in the C 1s spectra was set at 285.0 
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eV to correct sample charging. The spectrometer was previously calibrated with the peak of 
Ag 3d 5/2 (368.28 eV).
Infrared spectroscopy was performed using a Shimadzu Miracle 10. Before the 
measurements, all the samples have been freeze-dried. The number of scans was set to 45, 
the scanning range was set from 4000 to 400 cm-1 and the resolution step at 4 cm-1. The 
graphs were plotted using Origin Pro software 9.1.
The diffraction patterns of the NCubes and CM-NCubes were obtained using a Phillips 
X’pert PRO X-ray diffractometer, with theta-theta configuration, under the following 
conditions: CuKα radiation (λ = 1.5418 Å), scans in the 2θ range of 10-80° with a current 
of 40 mA, a voltage of 40 kV, and a scan rate of 2.8° min-1.
The thermal degradation of the samples was studied by means of TGA, using a TA 
Instruments TGA model Q50-0545 in platinum pans, with nitrogen flux of 60 ml min-1 for 
each sample. Samples of approximately 5 mg were heated from room temperature to 600 °C 
at a heating rate of 10 °C min-1, recording continuously the heat flow, sample temperature, 
sample weight and its time derivative.
Dynamic light scattering measurements were performed using a Zetasizer NanoZS90, 
Malvern instruments LTD. The measurements were carried out at 37°C and media with 
different pH and conductivity (H2O, DMEM, and aCSF), as well as different supplements 
(FBS, albumin, transferrin, and ferritin). For the hydrodynamic diameter measurements, the 
concentration for all the samples was adjusted to 100 μg ml-1. The Z potential measurements 
were carried out in ultrapure water at pH 5.5 and the conductivity was adjusted in the range 
30-100 μS cm-1. The attenuation of the samples during measurement was approximately 9. 
The size and the surface charge measurements represent the mean ± SD of 3 different 
measurements and with 17 runs in each measurement. Before each measurement, the 
samples were sonicated for ~10 s using a Bandelin ultrasonic probe at 8 W, to avoid the 
presence of aggregates during measurements, except in the case of the 24 h stability study.
ICP-OES was performed using an iCAP 6300 DUO Thermo spectrometer from Thermo 
Fisher Scientific. All chemical analyses performed by ICP-OES were affected by a 
systematic error of about 5%. Samples were dissolved in HCl/HNO3 3:1 (v/v) before 
measurements.
Mass spectroscopy (MS) was performed using a linear Trap Quadropole Orbitrap Velos Pro 
MS, coupled with an Ultimate 3000 HPLC. Raw MS files were processed with MaxQuant 
software version 1.6.6.0. Before the analysis, the samples were solubilized in 50 µl of 2% of 
sodium deoxycholate (SDC), 40 mM of chloroacetamide, 10 mM of tris(2-carboxyethyl) 
phosphine) (TCEP) and 100 mM of Tris HCl at pH 8, 100°C for 5 min, and digested with 1 
µg of trypsin at 37°C for 3 h. The digested samples were processed using the in-stage tip 
(iST) protocol. [32]
Concerning magnetic characterization, room temperature magnetic hysteresis loops were 
recorded by a vibrating sample magnetometer (VSM – 1.2H/CF/HT Oxford Instruments) in 
a magnetic field range ± 1 T, at room temperature.
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The local spin dynamics and the MRI contrast efficiency were assessed by means of 1H 
Nuclear Magnetic Resonance (NMR) relaxometric characterization. The NMR-dispersion 
profiles (Fig. S8-A, ESI†) were collected at room temperature by measuring the longitudinal 
and the transverse nuclear relaxation times T1 and T2, in the frequency range 10 kHz < ν < 
56.7 MHz for T1 and in the range 3.7 MHz < ν < 56.7 MHz for T2. A SMARTracer Stelar 
relaxometer was used to generate and detect the NMR signal in the 10 kHz-9.5 MHz range 
using the fast-field cycling technique; for the ν > 7 MHz range, a Stelar Spinmaster Fourier 
transform nuclear magnetic resonance (FT-NMR) spectrometer was employed, while for 
frequencies ν > 3.7 MHz, non-pre-polarized Saturation Recovery (SR) and Carr Purcell 
Meiboom Gill (CPMG) pulse sequences were used for T1 and T2 measurements, 
respectively. For frequencies ν <3.7 MHz, pre-polarized Saturation Recovery for T1 was 
adopted, and care was taken so that a sufficiently homogeneous magnetic field was present. 
The NMR relaxometry measurements were performed on CM-NCubes dispersed in milliQ 
water. NMR results at magnetic fields (frequencies) of 0.2 T (8.5 MHz), 0.5 T (21.3 MHz) 
and 1.33 T (56.7 MHz) reported in the paper were similar to the ones covered by the clinical 
imaging systems. The efficiency of the CM-NCubes dispersion in contrasting the magnetic 
resonance images was estimated according to the usual definition of nuclear relaxivity 
values r1 and r2: r1,2= [(1/T1,2 NP+water -1/T1,2 water)/c], where T1 and T2 represent the 
longitudinal and transverse nuclear relaxation times in the presence (NP + water) or absence 
(water) of CM-NCubes, and c is the concentration of the magnetic part of the sample.
The MRI experiments were performed at 8.5 MHz using an Artoscan Imager by Esaote SpA. 
The employed pulse sequence was an High resolution Spin Echo sequence with TR/TE/NEX 
= 5000 ms / 120 ms / 1, matrix = 256·192, FOV = 180·180. Here, TE is the echo time, TR 
the repetition time, and NEX the number of averages. The quantification of the signal 
intensity was performed using ImageJ, considering as control (100%) the signal of the water.
Magnetic hyperthermia was performed using a MagneTherm™ equipment from 
NanoTherics limited. The applied alternating magnetic field ranged from 12 to 20 mT and 
the corresponding frequencies ranged from 177 KHz to 1017 kHz. The samples were placed 
inside a 2 ml Nalgene tube which subsequently was placed inside a polystyrene case in order 
to reduce thermal fluctuations. The polystyrene case with the sample was placed inside a 
round coil, either 9 turns with a diameter of 44 mm (9 turn-44 mm) or 9 turns with a 
diameter of 56 mm (9 turn-56 mm), and the hyperthermia measurements lasted 2 h. The 
temperature was recorded every second using an Osensa optical fiber temperature probe.
Oxygen generation was recorded every 1 s using a Microx 4 trace fiber-optic oxygen meter 
with a PSt7-02 microsensor (PreSens, Germany), while the temperature was recorded every 
1 s using an OSENSA single channel optic fiber. Varying amounts of CM-NCubes (200, 500 
and 1000 μg ml-1) were placed in a 1.5 ml airtight Eppendorf vials with 0.5 ml of complete 
medium. Both of the sensors were placed through a hole in the cap and left for 30 min to 
equilibrate O2 and temperature levels. Afterward, 0.5 ml of 0, 0.1, 0.5, 1.0 or 2.0 mM H2O2 
were added in the vial, aiming at having final concentrations of H2O2 0, 0.05, 0.25, 0.5 and 1 
mM, and final concentrations of CM-NCubes 100, 250 and 500 μg ml-1.
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The antioxidant measurements were carried out by using an ABTS Antioxidant Assay Kit by 
Zen-Bio, Inc. following the manufacturer’s instructions. The antioxidant ability of the CM-
NCubes was compared with the antioxidant ability of Trolox (6-Hydroxy-2,5,7,8-
tetramethylchroman-2-carboxylic acid), which is a water-soluble analog of vitamin E, 
known for its strong antioxidant properties.
The drug loading and release studies were performed using an HPLC Shimadzu LC-20AT. 
The chromatographic separation was carried out using a C-18 column (150 mm × 4.6 mm 
i.d., 5 μm particle size). The mobile phase consisted of methanol and water (containing 
acetic acid 1%) and pumped in isocratic mode (80% MeOH- 20% H2O) with a flow rate of 
0.5 ml min-1. The elution of the analyte was monitored at 240 nm. The standard curve was 
prepared by dissolving 5 mg of SOR in 5 ml volume of the mobile phase and filtering using 
a 0.2 μm syringe filter. A concentration range of 0.1-325 μg ml-1 was prepared upon further 
serial dilution. To calculate the loading capacity after the loading, all the supernatants were 
collected, filtered and measured using the above conditions. For the release studies, at each 
time point, the samples were centrifuged at 15000 rpm for 1 h at 4°C and the supernatant of 
each solution was removed and replaced with a fresh one of the same volume. 20 μl of each 
supernatant was injected into the HPLC and analyzed using the parameters above described. 
The SOR peak was observed at 3.8-4.0 min.
For the loading of the CM-NCubes, 500 μg of sorafenib were mixed with 10 mg of NCubes 
in 2 ml final volume of water and sonicated with a Fisherbrand™ Q125 Sonicator (50% 
amplitude) for 10 min inside an ice bath. Subsequently, 2 ml of the cell-derived membrane in 
water (derived from 50 x 103cells) were added to the SOR-NCubes dispersion and sonicated 
for 20 min more, still inside the ice bath. Three cleanings with deionized water were carried 
out by spinning down the samples for 30 min at 16000 g at 4°C. All the supernatants were 
collected and analyzed with HPLC.
4.3 In vitro studies
In this study, the glioblastoma multiforme cell line U-251 MG (formerly known as U-373 
ATCC® HTB-17™), the neuroblastoma cell line SH-SY5Y (ATCC® CRL-2266™), the C8-
D1A cells [Astrocyte type I clone] (ATCC® CRL-2541™), and the bEnd.3 cells [BEND3] 
(ATCC® CRL-2299™) were used. U-251 MG, C8-D1A and bEnd.3 cells were cultured in 
T75 flasks using high glucose DMEM supplemented with 10% FBS, 1% P/S and 1% L-glu, 
and at normal culture conditions (37°C, 5% CO2), while SH-SY5Y were cultured in 
DMEM:F12 (1:1) supplemented with 10% FBS, 1% P/S and 1% L-glu at the same 
conditions as the other cell lines. For all the experiments the used cells were between 
passage 10 and passage 20. The medium during culture was changed every two days.
For the intracellular temperature studies, U-251 MG cells were seeded at a concentration of 
25000 cm-2, using a complete medium containing 25 mM (4-(2-hydroxyethyl)-1-piperazine 
ethanesulfonic acid, HEPES) in a Willco well (GWST-3512) with a glass bottom, and 
incubated at cell culture conditions overnight. After 24 h, half of the samples were treated 
with 250 μg ml-1 (treated sample) of CM-NCubes and left again for 24h in order to allow the 
nanostructures to be internalized by the cells. After 24 h, untreated and treated samples were 
stained using ER Thermo Yellow (300 nM for 30 min at 37°C), a fluorescent temperature 
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sensitive dye. The time-lapse fluorescence imaging was then performed by using a Nikon 
C2+ confocal laser microscope equipped with a 60× oil objective and by taking advantage of 
the automated focal control through the Nikon Perfect Focus System. Subsequently, the 
medium loaded with the fluorescent dye was discharged and replaced with the solution for 
imaging, which consisted of phenol red-free DMEM supplemented with 25mM of HEPES. 
The samples were left for 1 h at room temperature in order to equilibrate the temperature, 
and then the excess media was removed, leaving only 100 μl in the Willco dish. 
Fluorescence intensities (λex/em = 561/570<λem<1000 nm) were recorded every 10 s during 
the gentle addition of 20 μl of media containing a predetermined concentration of H2O2, and 
for 3 min after the addition of the media. Finally, fluorescence intensities were converted to 
temperature levels by following a calibration (3.9% decrement fluorescence °C-1) as 
reported elsewhere.[25a]
To evaluate the ability of the CM-NCubes to be internalized by cells typical of the BBB as 
well as by glioblastoma cells, and additionally to assess their ability to specifically target the 
homotypic U-251 MG cell line, we performed flow cytometry and confocal microscopy 
studies at two different time points (4 and 24 h), using four different cell lines (U-251 MG, 
SH-SY5Y, C8-D1A and bEnd.3), and two different coatings (cell membrane and commercial 
lipids coating). For the flow cytometry studies, the various types of cells were seeded in 24-
wells plate (Corning®) in triplicate at a density of 25000 cells cm-2, 24 h before the 
nanoparticle treatment. After 24 h the media were changed with media containing 10 μg ml-1 
of (3-octadecyl-2-[3-(3-octadecyl-2(3H)-benzoxazolylidene)-1-propenyl]-, perchlorate) 
(DiO) (Thermo Fisher) stained particles, and at predetermined time points the supernatant 
was removed and a gentle wash with DPBS for 3 times followed. Then, the cells were 
detached using 0.05 % trypsin-EDTA. Cells were centrifuged at 1500 rpm for 5 min and the 
pellet was gently re-dispersed in DPBS 1×. For the confocal studies, the various types of 
cells were seeded in 24-well plates with black walls and flat and clear bottom (Ibidi®) in 
triplicate at a density of 25000 cells cm-2, 24 h prior the nanoparticle treatment. After 24 h 
the media was changed with media containing 100 μg ml-1 of CM-NCubes and LP-NCubes 
and at predetermined time points the cells were washed three times with DPBS 1× and then 
fixed for 20 min at 4°C with paraformaldehyde (PFA, Sigma Aldrich, 4% in DPBS 1×). 
After the fixation, the cells were incubated for 30 min at room temperature with a blocking 
solution of goat serum (10% in DPBS 1×) and then stained for 30 min at 37°C with a 
solution containing TRITC-phalloidin 0.165 μM (Sigma Aldrich) and Hoechst 5 µg ml-1 
(Invitrogen). After staining, the cells were washed two times with DPBS 1×. The 
internalization of the CM- and LP- NCubes by the different cell lines was studied using flow 
cytometry (CM-NCubes in green λex/em= 488/525 nm) and confocal laser scanning 
microscopy on a Nikon C2+ system (actin filament in red λex/em= 561/585 nm, CM-NCubes 
in white, nuclei in blue λex/em=401/447 nm). For the flow cytometry studies the CM-
NCubes were stained with the DiO dye, the excitation and emission wavelengths of which 
are described above, while for the internalization studies using confocal microscopy 
unstained CM-NCubes were detected at the wavelength of 647 nm.
U-251 MG spheroids were formed following a modified protocol previously reported in the 
literature.[33] Briefly, each well of a 48-multiwell plate (Corning®) was covered with 100 μl 
of hot agarose solution in DPBS 1× (15 mg ml-1) and left for 30 min at room temperature to 
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cool down. Afterwards, 1 ml of complete DMEM containing 100·103 U-251 MG cells was 
added in each well. The multi-wells were incubated at 37°C and at 5% CO2 until the 
spheroids were completely formed at day 7. The medium was not changed until the end of 
the experiment, aiming at the creation of a hypoxic and low pH environment that simulates 
the tumor microenvironment. U-251 MG spheroids were characterized using optical 
microscopy (Fig. S12, ESI†), while plain spheroids and CM-NCubes treated spheroids were 
also characterized using scanning electron microscopy and energy dispersive X-ray analysis 
(Fig. S13, ESI†). Cross-section images using focused ion beam microscopy were also 
performed aiming at confirming the internalization of the particles by the spheroids (Fig. 
S14, ESI†).
Apoptosis and cell proliferation on the U-251 MG spheroids were assessed using the 
annexin V-FITC/PI (Thermo Fisher Scientific) assay as per manufacturer instructions.
At day 2 of the growing U-251 MG spheroids (in complete media containing HEPES), 500 
μg ml-1 of the SOR-CM-NCubes and the corresponding free sorafenib (10 μg ml-1) were 
added to the 48-multiwell containing the spheroids. Both the particles and the free drug were 
incubated 2 days before the initiation of the spheroid exposure to the alternating magnetic 
field, that lasted further 3 days. At day 5, the supernatant was removed, and the spheroids 
were transferred into 2 ml Nalgene vials with fresh complete media containing HEPES; each 
vial contained 5 spheroids and a volume of 500 μl.
Samples treated with sorafenib (SOR), cell membrane-coated nanocubes (CM-NCubes), 
sorafenib-loaded cell membrane nanocubes (SOR-CM-NCubes) and untreated samples were 
exposed to an AMF for 3 h per day for 3 days. For each of the above samples, a Nalgene 
tube with the same number of spheroids and the same treatment was kept in a water bath at 
37°C for 3 h without any exposure to the AMF. At day 8, the spheroids from each Nalgene 
tube were broken into single cells by pipetting and incubated with annexin V-FITC/PI 
following the manufacturer's protocols. Cells stained with annexin V-FITC/PI were 
evaluated using a Beckman Coulter cytoflex. Live cells (Annexin V- / PI-), early apoptotic 
cells (Annexin V+ / PI-), late apoptotic cells (Annexin V+ / PI+) and necrotic cells (Annexin 
V- / PI+) were analyzed using the Cytoflex software (Beckman Coulter). Unstained cells 
with and without particles were used as controls.
Caspase-3 and caspase-9 enzymatic activity were assessed using CaspGLOW™ Fluorescein 
Active assay kits (Thermo Fisher Scientific) following the manufacturer’s protocol. The 
samples and the applied treatments are described in the assessment of apoptosis and cell 
proliferation paragraph.
The generation of reactive oxygen and nitric oxide in the samples that underwent various 
treatments (see assessment of apoptosis and cell proliferation paragraph) was evaluated 
using the CellROX® Green Reagent (Thermo Fisher Scientific) and the (4-Amino-5-
Methylamino-2',7'-Difluorofluorescein Diacetate) (DAF-FM Diacetate) (Thermo Fisher 
Scientific) dyes following the manufacturer’s protocols.
To assess the ability to guide the CM-NCubes across the BBB and towards the glioblastoma 
site using a static magnetic field, an in vitro fluidic model of the BBB [14] was used. The 
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fluidic model consisted of two parallel channels (top and bottom channel) that were 
separated by a porous membrane, derived from 6 well falcon transwell inserts (3 µm pore 
size). After coating with gelatin 1%, the upper channel was seeded with 105 bEnd.3 cells, 
while the lower channel was seeded with 105 U-251 MG cells, that were left to grow for 5 
days (culture conditions were the same as aforementioned for the other experiments). After 5 
days of culture, the upper channel was placed under flow using an Ibidi® pump system with 
a flow rate of 12 ml min-1, of phenol red-free fully complemented cell culture medium 
(DMEM high glucose 10% FBS) containing 20 µg ml-1 of DiO-stained CM-NCubes. The 
accumulation of the CM-NCubes was achieved in the presence of a static magnetic field (13 
mm diameter, 10 mm width, grade N35 NdFeB, axial magnetization) positioned under the 
device for 2 min, and was thereafter evaluated through confocal imaging. The distribution of 
the CM-NCubes on the porous membrane of the dynamic BBB model was predicted by 
using the numerical model described in our previous study. [14] In particular, using the 
Matlab environment, we derived the sought distribution by numerically integrating the 
trajectories of nearly 1.25 million CM-NCubes released in the fluid stream and responding 
to the magnet field as point dipoles. [34] Relevant details are reported in the supporting 
information. The evaluation of the cellular internalization and the crossing ability of CM-
NCubes were evaluated with a similar approach. A 5 µg ml-1 dispersion of DiO-stained CM-
NCubes was pumped inside the upper channel of the system, with and without the presence 
of a static magnetic field at the aforementioned time (2 min) and flow rate. After 2 min, the 
systems used for the targeting experiment were disconnected from the pump and left in a 
static condition. After 72 h, bEnd.3 cells in the upper channel and U-251 MG cells in the 
lower one, in the presence of DiO-stained CM-NCubes, were fixed and stained with TRITC 
phalloidin and Hoechst (see the previous section for methodological details about fixation 
and staining), and were evaluated through confocal microscopy.
4.4 Statistical Analysis
The results were presented as mean ± standard deviation. Analyses comparing means of 
different treatment groups were performed using one-way ANOVA test (GraphPad Prism 7; 
GraphPad Software, Inc.), corrected for multiple comparisons by the Bonferroni method. 
Adjusted p-values lower than 0.05 were considered significant.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
Synthesis and characterization of MnO2-dopped iron oxide nanocubes (NCubes) and of cell 
membrane-coated NCubes (CM-NCubes). A) Schematic representation demonstrating the 
potential applications of the synthesized CM-NCubes; B) transmission electron microscopy 
image showing CM-NCubes (scale bar: 20 nm); C) Fourier-transformed infrared 
spectroscopy of NCubes and CM-NCubes, showing the presence of extra peaks in the range 
1500 - 3000 cm-1 (spectrum ii) that can be attributed to the successful coating with the cell 
membrane; D) X-ray diffraction pattern of CM-NCubes presenting the crystalline spinel 
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structure of Fe3O4 as well as the presence of Mn (peak at 2θ =38.6°; E) thermogravimetric 
analysis spectra showing the weight loss and the first derivative of the weight loss; the 
decrease of weight by 12 % in the CM-NCubes sample is attributed to the decomposition of 
the cell membrane coating (temperature range 100-500 °C); F) X-ray photoelectron 
spectrum presenting the elements (C, N, O, Mn and Fe) found on the surface of NCubes and 
of CM-NCubes; G1-G5) electron dispersive X-ray analysis and mapping of a single CM-
NCubes showing the presence and the distribution of carbon (C), iron (Fe), phosphorus (P) 
and manganese (Mn), proving the presence of an organic coating (scale bar: 10 nm); G6) 
electron dispersive X-ray analysis spectrum showing all the elements present on the surface 
of CM-NCubes. Increase percentages of carbon, at the bottom right corner of the 
corresponding EDS image, are present due to the carbon film-coated TEM grid. In addition, 
Cu and U present in the EDS spectrum are attributed to the TEM grid as well as to the 
staining of the CM-NCubes with uranyl acetate.
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Figure 2. 
Dynamic light scattering studies presenting the hydrodynamic diameter of NCubes and CM-
NCubes, after their interaction with different proteins (or their combination) found both in 
aCSF and in the blood plasma. A1) NCubes in aCSF + 10% FBS, A2) NCubes in aCSF + 
transferrin 200 μg ml-1, A3) NCubes in aCSF + albumin 2.3 mg ml-1, A4) NCubes in aCSF 
+ Ferritin 1.5 ng ml-1, and A5) NCubes + albumin 2.3 mg ml-1 + transferrin 200 μg ml-1 + 
ferritin 1.5 ng ml-1; B1) CM-NCubes in aCSF + 10% FBS, B2) CM-NCubes in aCSF + 
transferrin 200 μg ml-1, B3) CM-NCubes in aCSF + albumin 2.3 mg ml-1, B4) CM-NCubes 
in aCSF + ferritin 1.5 ng ml-1 and B5) NCubes + albumin 2.3 mg ml-1 + transferrin 200 μg 
ml-1 + ferritin 1.5 ng ml-1. All the measurements were performed in artificial cerebrospinal 
fluid at 37°C using a concentration of 100 μg ml-1 for both NCubes and CM-NCubes. The 
presented results derive from the average values of three different measurements at each 
time point.
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Figure 3. 
A) Hysteresis loops of NCubes (black curve – Ms = 57 emu g-1) and CM-NCubes (red curve 
– Ms = 40 emu g-1) normalized to the inorganic component; B) temperature increment over 
time, after the exposure of plain media, NCubes, and CM-NCubes dispersed in different 
media to an AMF of 20 mT – 750 KHz obtained with a 9 turn-44 mm coil; C) SAR values of 
CM-NCubes after their exposure at various intensities of AMFs using 2 different diameter 
coils; D) SAR values of NCubes and CM-NCubes in various media; E) ILP values of CM-
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NCubes after their exposure at various intensities of AMFs using 2 different diameter coils; 
D) ILP values of NCubes and CM-NCubes in various media (n = 3).
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Figure 4. 
A) Oxygen generation and B) temperature increment after the reaction of different 
concentrations of CM-NCubes (100, 250 and 500 μg ml-1) with increasing concentrations of 
H2O2 (0, 0.05, 0.25, 0.5 and 1 mM). H2O2 1 mM reacting with plain medium (H2O2 N. 
Control) was used as a negative control both in the oxygen generation and in the temperature 
measurements; C) confocal images showing the difference of fluorescence intensity in 
U-251 MG cells incubated with 250 μg ml-1 of CM-NCubes overnight after the addition of 
plain DMEM supplemented with 25 mM HEPES (control), and after the addition of 100 μM 
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of H2O2 (at 80 s) (treated); D1) fluorescence intensity of the temperature sensitive dye in the 
control samples (addition of plain DMEM supplemented with HEPES in U-251 MG cultures 
incubated with 250 μg ml-1 of CM-NCubes overnight), D2) fluorescence intensity of the 
temperature sensitive dye after the addition of 100 μM of H2O2 in U-251 MG cultures 
incubated with 250 μg ml-1 of CM-NCubes overnight, D3) fluorescence intensity of the 
temperature sensitive dye after the addition of 100 μM of H2O2 in non-treated U-251 MG 
cultures (N. Control), D4) intracellular temperature of the control sample which remains 
stable at approximately 30°C; D5) intracellular temperature increment up to approximately 
33°C after the addition of 100 μM of H2O2 in U-251 MG cultures incubated with 250 μg 
ml-1 of CM-NCubes overnight, D6) intracellular temperature of the negative control sample 
which remains stable after the addition of 100 μM of H2O2 in non-treated U-251 MG 
cultures
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Figure 5. 
A) Flow cytometry graphs and corresponding confocal images of internalized CM-NCubes 
and LP-NCubes, after 4 h, by C8-D1A, bEnd.3, U-251 MG and SH-SY5Y cells. For the 
flow cytometry analysis, all the cell lines were treated with DiO-stained CM-NCubes and 
LP-NCubes (in the histograms with the green color are depicted the fluorescence negative 
cells (-) and in blue the fluorescence positive cells (+)); for the confocal images the particles 
were unstained (nuclei in blue; f-actin in red; CM-NCubes in white); B) bar plots 
summarizing the cells’ fluorescent intensities as they were calculated from the flow 
cytometry analysis. (n =3, one-way ANOVA, a detailed statistical analysis is provided at 
Table S6, ESI†).
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Figure 6. 
A) Percentage of DiO-stained CM-NCubes crossing a bEnd.3 monolayer resembling an in 
vitro BBB model, with respect to the initial CM-NCubes seeded in the abluminal part of the 
Transwell© insert; B) 2D and C) 3D confocal acquisitions showing CM-NCubes internalized 
by U-251 MG cells after BBB crossing (nuclei in blue; factin in red; CM-NCubes in green). 
Scale bar for B: 25μm, For C: x: 0.10 μm, y: 0.10 μm, z: 0.13 μm; width: 53.25 μm, height: 
53.25 μm, depth: 8.88 μm. n = 3, one-way ANOVA, p<0.5
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Figure 7. 
A) Pseudo colored fluorescence density distribution of the CM-NCubes after their exposure 
to a static magnetic field placed under the fluidic BBB channel; B) Distribution of DiO-
stained (green) CM-NCubes overlapped with a dark field image of the fluidic channel; C) 
density contour plot (a.u.) of the captured CM-NCubes, as predicted by the numerical model 
(the dashed line denotes the top edge of the underlying magnet).
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Figure 8. 
Internalization of DiO-stained CM-NCubes by both bEnd.3 cells and U-251 MG cells 
seeded in the fluidic BBB in vitro system with and without the presence of a static magnet 
(Nuclei in blue; F-actin in red; CM-NCubes in green).
Tapeinos et al. Page 35
Adv Healthc Mater. Author manuscript; available in PMC 2019 September 20.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
Figure 9. 
Bar graphs presenting A) the AMF-induced apoptosis, B) the n-fold increase in fluorescent 
intensity related to the enzymatic activity of cas-3, C) the n-fold increase in fluorescent 
intensity related to the enzymatic activity of cas-9, D) the n-fold increase in fluorescent 
intensity related to the generation of ROS and E) the n-fold increase in fluorescent intensity 
related of RNS in U-251 MG spheroids with no treatment (CTRL), treated with sorafenib 
(SOR), treated with cell membrane-coated nanocubes (CM-NCubes), treated with sorafenib-
loaded cell membrane-coated nanocubes (SOR-CM-NCubes), without or with exposure to 
Tapeinos et al. Page 36
Adv Healthc Mater. Author manuscript; available in PMC 2019 September 20.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
an alternating magnetic field (AMF), after 3 consecutive days of exposure (3 h every day); n 
= 3, one-way ANOVA, a detailed statistical analysis is provided in the ESI†.
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